Healwell AI Inc.
HWAIF
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.60
FAIR PRICE
$0.87
MARGIN
$0.27
P/E Ratio
N/A
Div. Yield
N/A
ROE
-56.9%
Market Cap
$250M
Small-cap
COMING SOON
Get notified when HWAIF's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Aaron Leibtag
COUNTRY
CA
HEADQUARTERS
Toronto
SECTOR
Healthcare
EXCHANGE
OTC
METHODOLOGY
How we calculate HWAIF's fair price
Healwell AI Inc.'s fair price of $0.87 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $0.60, HWAIF trades 44.6% below its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting HWAIF's risk profile.
RELATIVE · 30%
Comparing HWAIF's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for HWAIF, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for HWAIF.
Explore on BuliosFAQ
What is the fair price of HWAIF?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Healwell AI Inc. is $0.87. At the current market price of $0.60, HWAIF trades 44.6% below its calculated fair value.
Is HWAIF overvalued or undervalued?+
Healwell AI Inc. is currently undervalued based on our valuation model. The stock trades at $0.60, which is 44.6% below the fair price of $0.87.
How often is HWAIF's fair price updated?+
We update fair price calculations for HWAIF daily after market close. The current fair price of $0.87 incorporates the latest market data and sector multiples.
What factors affect HWAIF's fair price calculation?+
HWAIF's fair price of $0.87 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -56.9%.
Is HWAIF a good buy right now?+
At $0.60, HWAIF trades 44.6% below our fair value estimate of $0.87. The stock is currently undervalued. ROE stands at -56.9% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does HWAIF pay dividends?+
HWAIF does not currently pay a dividend.